1.Splicing abnormalities caused by a novel mutation in the PHKA2 gene in children with glycogen storage disease type IX.
Zhi Hua ZHANG ; Bi Xia ZHENG ; Yu Jie ZHUO ; Yu JIN ; Zhi Feng LIU ; Yu Can ZHENG
Chinese Journal of Hepatology 2023;31(4):428-432
Objective: Glycogen storage disease type IX (GSD-IX) is a rare primary glucose metabolism abnormality caused by phosphorylase kinase deficiency and a series of pathogenic gene mutations. The clinical characteristics, gene analysis, and functional verification of a mutation in a child with hepatomegaly are summarized here to clarify the pathogenic cause of the disease. Methods: The clinical data of a child with GSD-IX was collected. Peripheral blood from the child and his parents was collected for genomic DNA extraction. The patient's gene diagnosis was performed by second-generation sequencing. The suspected mutations were verified by Sanger sequencing and bioinformatics analysis. The suspected splicing mutations were verified in vivo by RT-PCR and first-generation sequencing. Results: Hepatomegaly, transaminitis, and hypertriglyceridemia were present in children. Liver biopsy pathological examination results indicated glycogen storage disease. Gene sequencing revealed that the child had a c.285 + 2_285 + 5delTAGG hemizygous mutation in the PHKA2 gene. Sanger sequencing verification showed that the mother of the child was heterozygous and the father of the child was of the wild type. Software such as HSF3.1 and ESEfinder predicted that the gene mutation affected splicing. RT-PCR of peripheral blood from children and his mother confirmed that the mutation had caused the skipping of exon 3 during the constitutive splicing of the PHKA2 gene. Conclusion: The hemizygous mutation in the PHKA2 gene (c.285 + 2_285 + 5delTAGG) is the pathogenic cause of the patient's disease. The detection of the novel mutation site enriches the mutation spectrum of the PHKA2 gene and serves as a basis for the family's genetic counseling.
Child
;
Humans
;
Exons
;
Glycogen Storage Disease/genetics*
;
Hepatomegaly/genetics*
;
Mutation
;
Phosphorylase Kinase/genetics*
;
Male
;
Female
2.Genetic analysis of a child with glycogen storage disease type IXa due to a novel variant in PHKA2 gene.
Ganye ZHAO ; Wenzhe SI ; Xuechao ZHAO ; Li'na LIU ; Conghui WANG ; Xiangdong KONG
Chinese Journal of Medical Genetics 2022;39(9):988-991
OBJECTIVE:
To explore the genetic etiology of a patient with glycogen storage diseases.
METHODS:
Clinical data of child and his parents were collected. The genes associated with glycogen storage diseases were subjected to high-throughput sequencing to screen the variants. Candidate variant was validated by Sanger sequencing. Pathogenicity of the variant was predicted by bioinformatic analysis.
RESULTS:
High-throughput sequencing results showed that the boy has carried a hemizygous c.749C>T (p.S250L) variant of the PHKA2 gene. Sanger sequencing verified the results and confirmed that it was inherited from his mother. This variant was unreported previously and predicted to be pathogenic by bioinformatic analysis.
CONCLUSION
The patient was diagnosed with glycogen storage disease type IXa due to a novel c.749C>T (p.S250L) hemizygous variant of the PHKA2 gene. High-throughput sequencing can facilitate timely and accurate differential diagnosis of glycogen storage disease type IXa.
Child
;
Family
;
Genetic Testing
;
Glycogen Storage Disease/pathology*
;
High-Throughput Nucleotide Sequencing/methods*
;
Humans
;
Male
;
Mutation
;
Phosphorylase Kinase/genetics*
3.The Significance of Clinical and Laboratory Features in the Diagnosis of Glycogen Storage Disease Type V: A Case Report.
Hyung Jun PARK ; Ha Young SHIN ; Yu Na CHO ; Seung Min KIM ; Young Chul CHOI
Journal of Korean Medical Science 2014;29(7):1021-1024
Glycogen storage disease type V (GSD-V) is the most common disorder of muscle glycogenosis with characteristic clinical and laboratory findings. A 32-yr-old woman complained of exercise intolerance and myoglobulinuria since early adolescence. She reported several episodes of second-wind phenomenon. Physical examination did not show any neurological abnormality, including fixed muscle weakness or atrophy. Serum creatine kinase level was 1,161 IU/L at rest. The result of the non-ischemic forearm exercise test was compatible with GSD-V. Mutation analysis identified the compound heterozygous mutations of the PYGM, p.D510fs and p.F710del, which has not yet been reported in Korea. The present case recognizes that detail clinical and laboratory analysis is the first step in the diagnosis of GSD-V.
Adult
;
Base Sequence
;
Creatine Kinase/blood
;
Exons
;
Female
;
Frameshift Mutation
;
Gene Deletion
;
Genotype
;
Glycogen Phosphorylase, Muscle Form/genetics
;
Glycogen Storage Disease Type V/*diagnosis/genetics/pathology
;
Humans
;
Pedigree
;
Sequence Analysis, DNA